Synthesis of imidazol-2-yl amino acids by using cells from alkane-oxidizing bacteria

Applied and Environmental Microbiology

Volumn 69, Issue 3, 2003, Pages 1670-1679

  Mikolasch, Annett ^a   Hammer, Elke ^a   Schauer, Frieder ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; DERIVATIVES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS (CHEMICAL);

PRODUCT PATTERN;

AMINO ACIDS;

ACETAMIDE DERIVATIVE; ALKANE; AMINO ACID DERIVATIVE; BUTYRIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE;

AMINO ACID;

ARTICLE; BACTERIAL STRAIN; BACTERIUM; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG SYNTHESIS; GORDONIA RUBRIPERTINCTUS; GORDONIA TERRAE; MASS SPECTROMETRY; NOCARDIA ASTEROIDES; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION; RHODOCOCCUS ERYTHROPOLIS; STRAIN DIFFERENCE;

6-AMINOCAPROIC ACID; ACETAMIDES; ALKANES; AMINO ACIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GORDONIA BACTERIUM; GRAM-POSITIVE BACTERIA; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NOCARDIA; OXIDATION-REDUCTION; RHODOCOCCUS;

BACTERIA (MICROORGANISMS); GORDONIA RUBRIPERTINCTUS; GORDONIA TERRAE; NOCARDIA; NOCARDIA ASTEROIDES; RHODOCOCCUS; RHODOCOCCUS ERYTHROPOLIS;

EID: 0037335928     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.69.3.1670-1679.2003     Document Type: Article

References (56)

1. Alexander, J. C., J. R. Schuh, and R. J. Gorczynski. December 1996. Epoxysteroidal aldosterone antagonist and angiotensin II antagonist combination therapy for treatment of cardiovascular disorders, including congestive heart failure. PCT Int. Appl. WO 96 40 257.
2. Andreoni, V., S. Bernasconi, M. Colombo, J. B. van Beilen, and L. Cavalca. 2000. Characterization of Rhodococcus sp. strain 1BN bearing alkane (alk) and naphthalene (nar) catabolic pathways. Environ. Microbiol. 2:572-577.
3. Barger, G., and H. H. Dale. 1910. 4-β-Aminoethylglyoxaline (β-iminazolylethylamine) and the other active principles of ergot. J. Chem. Soc. 97:2592-2595.
4. Black, J. W., W. A. M. Duncan, G. J. Durant, C. R. Ganellin, and M. E. Parsons. 1972. Definition and antagonism of histamine H2-receptors. Nature (London) 236:385-390.
5. 2-receptor antagonist. Gastroenterology 74:339-347.
6. Brooks, D. P., T. A. Fredrickson, J. Weinstock, R. R., Jr. Ruffolo, R. M. Edwards, and M. Gellai. 1992. Antihypertensive activity of the nonpeptide angiotensin II receptor antagonist, SK & F 108566, in rats and dogs. NaunynSchmiedeberg's Arch. Pharmacol. 345:673-678.
7. Cardini, G., and P. Jurtshuk. 1968. Cytochrome P-450 involvement in the oxidation of n-octane by cell-free extracts of Corynebacterium sp. strain 7E1C. J. Biol. Chem. 243:6070-6072.
8. Carini, D. J., J. V. Duncia, A. L. Johnson, A. T. Chiu, W. A. Price, P. C. Wong, and P. B. M. W. Timmermans. 1990. Part VI. Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensives. J. Med. Chem. 33:1330-1336.
9. Catto, A., A. Rossi, A. Leonardi, R. Testa, and D. Nardi. 1989. Synthesis and anticonvulsant evaluation of 1,2-diphenylethane derivatives, potential metabolites of denzimol. Farmaco (Lausanne) 44:595-607.
10. Dale, H. H., and P. P. Laidlaw. 1910. The physiological action of β-iminazolylethylamine. J. Physiol. Lond. 41:318-344.
11. Dale, H. H., and P. P. Laidlaw. 1911. Further observations on the action of β-iminazolylethylamine. J. Physiol. Lond. 43:182-195.
12. Davis, J. B., and R. L. Raymond. 1961. Oxidation of alcylsubstituted cyclic hydrocarbons by a Nocardia during growth on n-alkanes. Appl. Microbiol. 9:383-388.
13. Dean-Raymond, D., and M. Alexander. 1977. Bacterial metabolism of quaternary ammonium compounds. Appl. Environ. Microbiol. 33:1037-1041.
14. do Socorro de Souza Furtado, M., and P. S. Minami. 1997. In vitro susceptibility tests of dermatophytes to griseofulvin and imidazole derivatives. Rev. Microbiol. 28:110-115.
15. Dubini, F., L. Riviera, C. Cocuzza, and M. G. Bellotti. 1992. Antibacterial, antimycotic and trichomonicidal activity of a new nitroimidazole (EU 11100). J. Chemother. 6:342-346.
16. Dutta, T. K., and S. Harayama. 2001. Biodegradation of n-alkylcycloalkanes and n-alkylbenzenes via new pathways in Alcanivorax sp. strain MBIC 4326. Appl. Environ. Microbiol. 67:1970-1974.
17. Fedorak, P. M., D. L. Coy, and T. M. Peakman. 1996. Microbial metabolism of some 2,5-substituted thiophenes. Biodegradation 7:313-327.
18. Fritsche, W. 1968. Der Einfluß der Kohlenstoffquelle auf das Wachstum, den Proteingehalt und das Enzymmuster von Candida guilliermondii. Z. Allg. Mikrobiol. 8:91-99.
19. 3-receptor histamine antagonists. J. Med. Chem. 39:3806-3813.
20. Goodfellow, M. 1971. Numerical taxonomy of some Nocardioform bacteria. J. Gen. Microbiol. 69:33-80.
21. Graziani, G., P. Cazzulani, C. Luca, G. Nava, and R. Testa. 1983. Denzimol, a new anticonvulsant drug. II. General pharmacological activities. Arzneim.-Forsch. 33:1161-1168.
22. Graziani, G., F. Tirone, E. Barbadoro, and R. Testa. 1983. Denzimol, a new anticonvulsant drug. I. General anticonvulsant profile. Arzneim.-Forsch. 33:1155-1160.
23. Groth, I., P. Schumann, N. Weiss, K. Martin, and F. A. Rainey. 1996. Agrococcus jenensis gen. nov., sp. nov., a new genus of actinomycetes with diaminobutyric acid in the cell wall. Int. J. Syst. Bacteriol. 46:234-239.
24. Hetzheim, A., C. Leschke, C. Kerstan, B. Weiher, E. Morgenstern, and E. Göres. August 1989. Verfahren zur Synthese neuer 1-substituierter 2-Morpholino-4-aryl-imidazole mit anticonvulsiver Wirkung. German patent 290,194.
25. Hetzheim, A., A. Irmscher, and B. Weiher. August 1990. Neue anticonvulsiv wirksame 1-substituierte 2-Arylamino-4-aryl-imidazole und ihr Syntheseverfahren. German patent 296,918.
26. Hetzheim, A., C. Kerstan, B. Weiher, and E. Morgenstern. June 1990. Verfahren zur Synthese neuer 1-substituierter 2-Piperidino-4-aryl-imidazole mit anticonvulsiver Wirkung. German patent 294,940.
27. Hetzheim, A., O. Peters, and H. Beyer. 1967. Über die Ringumwandlung von 2-Amino-3-phenacyl-1.3. 4-oxadiazoliumhalogeniden mit Aminen zu 1.2.-Diamino-imidazol-Derivaten. Chem. Ber. 100:3418-3426.
28. Hill, D. T., G. R. Girard, J. Weinstock, R. M. Edwards, E. F. Weidley, E. Ohlstein, C. E. Peishoff, E. Baker, and N. Aiyar. 1995. D- and L-N-[(1-benzyl-1H-imidazol-5-yl)-alkyl]-amino acids as angiotensin II AT-1 antagonists. Bioorg. Med. Chem. Lett. 5:19-24.
29. Holt, J. G., N. R. Krieg, P. H. A. Sneath, J. T. Staley, and S. T. Williams. 1994. Bergey's manual of determinative bacteriology. The Williams & Wilkins Co., Baltimore, Md.
30. Hommel, R., and C. Ratledge. 1992. Biosynthetic mechanisms to low molecular weight surfactants and their precursor molecules, p. 3-63. In N. Kosaric (ed.), Biosurfactants: production - properties - application. Marcel Dekker, New York, N.Y.
31. Hundt, K., M. Wagner, D. Becher, E. Hammer, and F. Schauer. 1998. Effect of selected environmental factors on degradation and mineralization of biaryl compounds by the bacterium Ralstonia pickettii in soil and compost. Chemosphere 36:2321-2335.
32. Keenan, R. M., J. Weinstock, J. A. Finkelstein, R. G. Franz, D. E. Gaitanopoulos, D. R. Girard, D. T. Hill, T. M. Morgan, J. M. Samanen, et al. 1993. Potent nonpeptide angiotensin II receptor antagonists. 2. 1-(Carboxybenzyl)imidazole-5-acrylic acids. J. Med. Chem. 36:1880-1892.
33. Kreisel, H., and F. Schauer. 1987. Methoden des mykologischen Laboratoriums, p. 103-104. Gustav Fischer Verlag, Stuttgart, Germany.
34. Lechevalier, M. P., and H. A. Lechevalier. 1985. Biology of actinomycetes not belonging to the genus Streptomyces, p. 315-358. In A. L. Demain and N. A. Solomon (ed.), Biology of industrial microorganisms. Benjamin-Cummings, San Francisco, Calif.
35. Malachowsky, K. J., T. J. Phelps, A. B. Teboli, D. E. Minnikin, and D. C. White. 1994. Aerobic mineralization of trichloroethylene, vinyl chloride, and aromatic compounds by Rhodococcus species. Appl. Environ. Microbiol. 60:542-548.
36. Merlos, M., A. Casas, A. Grauß, and J. Castaner. 1997. Eprosartan. Antihypertensive angiotensin II antagonist. Drugs Future 22:1079-1085.
37. Morgan, P., and R. J. Watkinson. 1994. Biodegradation of components of petroleum, p. 1-31. In C. Ratledge (ed.), Biochemistry of microbial degradation. Kluwer Academic Publishers, Dordrecht, The Netherlands.
38. Nardi, D., A. Tajana, A. Leonardi, R. Pennini, F. Portioli, M. J. Magistretti, and A. Subissi. 1981. Synthesis and anticonvulsant activity of N-(benzoylalkyl)imidazoles and N-(ω-phenyl-ω-hydroxyalkyl)imidazoles. J. Med. Chem. 24:727-731.
39. Petersen, M., M. Edelsten, V. F. Nielsen, A. Scarpellini, S. Skytte, and C. Slot. 1993. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int. J. Pharm. (Amsterdam) 90:247-254.
40. Poole, P. R., and G. Whitaker. 1997. Biotransformation of 6-pentyl-2-pyrone by Botrytis cinerea in liquid cultures. J. Agric. Food Chem. 45:249-252.
41. Ratledge, C. 1978. Degradation of aliphatic hydrocarbons, p. 1-46. In R. J. Watkinson (ed.), Developments in biodegradation of hydrocarbons - 1. Applied Science, London, United Kingdom.
42. Raymond, R. L., V. W. Jamison, and J. O. Hudson. 1967. Microbial hydrocarbon co-oxidation I. Oxidation of mono- and dicyclic hydrocarbons by soil isolates of the genus Nocardia. Appl. Microbiol. 15:857-865.
43. Robertson, D. W., J. H. Krushinski, E. E. Beedle, J. D. Leander, D. T. Wong, and R. C. Rathbun. 1986. Structure-activity relationships of (arylalkyl)imidazole anticonvulsants: comparison of the (fluorenylalkyl)imidazoles with nafimidone and denzimol. J. Med. Chem. 29:1577-1586.
44. Roth, H. J., and H. Fenner. 1994. Pharmazeutische Chemie III Arzneistoffe. Georg Thieme Verlag, Stuttgart, Germany.
45. Schauer, F. 1981. Untersuchungen zum Abbau von n-Dodecan durch Pseudomonas aeruginosa 7./4II. Ph.D. thesis. University of Greifswald, Greifswald, Germany.
46. Schwartz, J. C., J. M. Arrang, M. Garbarg, H. Pollard, and M. Ruat. 1991. Histaminergic transmission in the mammalian brain. Physiol. Rev. 71:1-51.
47. Smits, T. H. M., M. Röthlisberger, B. Witholt, and J. B. van Beilen. 1999. Molecular screening for alkane hydroxylase genes in Gram-negative and Gram-positive strains. Environ. Microbiol. 1:307-317.
48. Tsukamura, M. 1967. Identification of Mycobacteria. Tubercle (London) 48:311-338.
49. Urbanik, E., J. Zabielska-Matejuk, A. Skrzypczak, and J. Pernak. 1998. Antifungal properties of new imidazolium chlories against Coniophora puteana (Schum.: Fr.) Karst, Trametes versicolor (L.: Fr.) Pilat and Chaetomium globosum (Kunze: Fr.). Mater. Org. (Berlin) 31:247-263.
50. Warhurst, A. M., and C. A. Fewson. 1994. Biotransformation catalyzed by the genus Rhodococcus. Crit. Rev. Biotechnol. 14:29-73.
51. Webley, D. M., R. B. Duff, and V. C. Farmer. 1956. Evidence for β-oxidation in the metabolism of saturated aliphatic hydrocarbons by soil species of Nocardia. Nature 178:1467-1468.
52. Weide, H., and F. Schauer. 1981. Induction of enzymes for n-alkane degradation in two strains of Pseudomonas aeruginosa, p. 167-170. In M. MooYoung, C. W. Robinson, and C. Vezina (ed.), Advances in biotechnology, vol. 1. Pergamon Press, Toronto, Canada.
53. Werbrouck, S. P. O., and P. C. Debergh. 1996. Imidazole fungicides and paclobutrazol enhance cytokinin-induced adventitious shoot proliferation in araceae. J. Plant Growth Regul. 15:81-85.
54. Werbrouck, S. P. O., P. Redig, H. A. Van Onckelen, and P. C. Debergh. 1996. Gibberellins play a role in the interaction between imidazole fungicides and cytokinins in araceae. J. Plant Growth Regul. 15:87-93.
55. White, G. F., and N. J. Russell. 1994. Biodegradation of anionic surfactants and related molecules, p. 143-177. In C. Ratledge (ed.), Biochemistry of microbial degradation. Kluwer Academic Publishers, Dordrecht, The Netherlands.
56. Whyte, L. G., J. Hawari, E. Zhou, L. Bourbonniere, W. E. Inniss, and C. W. Greer. 1998. Biodegradation of variable-chain-length alkanes at low temperatures by a psychrotrophic Rhodococcus sp. Appl. Environ. Microbiol. 64:2578-2584.